A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
Public ClinicalTrials.gov record NCT05117489. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b, Open-Label Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Adult Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
Study identification
- NCT ID
- NCT05117489
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Corcept Therapeutics
- Industry
- Enrollment
- 70 participants
Conditions and interventions
Conditions
Interventions
- Miricorilant 150 mg Drug
- Miricorilant 100 mg Drug
- Miricorilant 50 mg Drug
- Miricorilant 10 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 22, 2021
- Primary completion
- Jan 28, 2024
- Completion
- Jan 28, 2024
- Last update posted
- Aug 18, 2024
2021 – 2024
United States locations
- U.S. sites
- 9
- U.S. states
- 4
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 207 | Chandler | Arizona | 85224 | — |
| Site 209 | Tucson | Arizona | 85712 | — |
| Site 214 | Panorama City | California | 91402 | — |
| Site 233 | Santa Ana | California | 92704 | — |
| Site 211 | Austin | Texas | 78757 | — |
| Site 213 | Edinburg | Texas | 78539 | — |
| Site 305 | Houston | Texas | 77079 | — |
| Site 212 | San Antonio | Texas | 78229 | — |
| 226 | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05117489, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2024 · Synced Jul 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05117489 live on ClinicalTrials.gov.